[1]Isakova T, Wahl P, Vargas G S, et al. Fibroblast
growth factor 23 is elevated before parathyroid hormone
and phosphate in chronic kidney disease[J]. Kidney Int,
2011,79(12):1370-1378.
[2]Lu X, Hu M C. Klotho/FGF23 Axis in Chronic
Kidney Disease and Cardiovascular Disease[J]. Kidney Dis
(Basel), 2017,3(1):15-23.
[3]Gao S, Xu J, Zhang S, et al. Meta-Analysis of the
Association between Fibroblast Growth Factor 23 and
Mortality and Cardiovascular Events in Hemodialysis
Patients[J]. Blood Purif, 2019,47 Suppl 1(Suppl 1):24-30.
[4]Salam S, Gallagher O, Gossiel F, et al. Vascular
calcification relationship to vascular biomarkers and bone
metabolism in advanced chronic kidney disease[J]. Bone,
2021,143:115699.
[5]Fayed A, Elnokeety M M, Attia K, et al. Calcification
of abdominal aorta in patients recently starting hemodialysis:
A single-center experience from Egypt[J]. Saudi J Kidney Dis
Transpl, 2019,30(4):819-824.
[6]Memmos E, Papagianni A. New Insights into the
Role of FGF-23 and Klotho in Cardiovascular Disease in
Chronic Kidney Disease Patients[J]. Curr Vasc Pharmacol,
2021,19(1):55-62.
[7]Zhang H, Li G, Yu X, Yang J, Jiang A, Cheng H, Fu
J, Liang X, Liu J, Lou J,Wang M, Xing C, Zhang A, Zhang
M, Xiao X, Yu C, Wang R, Wang L, Chen Y, Guan T,Peng A,
Chen N, Hao C, Liu B, Wang S, Shen D, Jia Z, Liu Z; China
Dialysis Calcification Study Group. Progression of Vascular
Calcification and Clinical Outcomes in Patients Receiving
Maintenance Dialysis. JAMA Netw Open. 2023 May 1;6(5):
e2310909.
[8]Daryadel A, Bettoni C, Haider T, et al. Erythropoietin
stimulates fibroblast growth factor 23 (FGF23) in mice and
men[J]. Pflugers Arch, 2018,470(10):1569-1582.
[9]Hanudel M R, Eisenga M F, Rappaport M, et al.
Effects of erythropoietin on fibroblast growth factor 23 in mice
and humans[J]. Nephrol Dial Transplant, 2019,34(12):2057-
2065.
[10]Noonan M L, Clinkenbeard E L, Ni P, et al.
Erythropoietin and a hypoxia-inducible factor prolyl
hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a
model of chronic kidney disease (CKD)[J]. Physiol Rep,
2020,8(11):e14434.
[11]Durlacher-Betzer K, Hassan A, Levi R, et al.
Interleukin-6 contributes to the increase in fibroblast growthfactor 23 expression in acute and chronic kidney disease[J].
Kidney Int, 2018,94(2):315-325.
[12]Glosse P, Fajol A, Hirche F, et al. A high-fat diet
stimulates fibroblast growth factor 23 formation in mice
through TNFα upregulation[J]. Nutr Diabetes, 2018,8(1):36.
[13]Ishigami J, Taliercio J T, Feldman H I, et al.
Fibroblast Growth Factor 23 and Risk of Hospitalization with
Infection in Chronic Kidney Disease: The Chronic Renal
Insufficiency Cohort (CRIC) Study[J]. J Am Soc Nephrol,
2020,31(8):1836-1846.